Deborah Kilpatrick, MS, PhD
Evidation Health, San Mateo, California

Deborah Kilpatrick, PhD is the CEO of Evidation Health, a digital health company backed by B Capital Group, GE Ventures, Sanofi Ventures, AMV, and Rock Health. Evidation Health quantifies health outcomes and product value in the digital era of medicine using medical, behavioral and contextual data in connected populations. Prior to her role at Evidation Health, Deborah was the Chief Commercial Officer of genomic diagnostics company CardioDx, which was named in the Wall Street Journal Technology Innovation Awards and TIME Magazine's Top 10 Medical Breakthroughs. Earlier in her career, Deborah held multiple leadership roles at Guidant Corporation, including Research Fellow, Director of R&D, and Director of New Ventures.  She chairs the Georgia Tech College of Engineering Advisory Board, sits on the Leadership Board for Santa Clara University's College of Arts and Sciences, and is a Fellow of the American Institute of Medical and Biological Engineering. Deborah is a co-founder of the MedtechVision Conference now held annually in Silicon Valley, and she has been named to FierceBiotech’s Top Women in Biotech, FierceMedicalDevice’s Top Women in Medtech, and Silicon Valley Business Journal’s 100 Women of Influence. She holds B.S., M.S. and Ph.D. degrees in engineering, with a minor in applied mathematics, from Georgia Tech.